Information Technology Reference
In-Depth Information
Tabl e 8. 9 Articles that cite Chin et al.'s 2009 article (Chin et al. 2009 ) and their citation counts
as of November 2011
Stadtfeld et al. ( 2010 )
Aberrant silencing of imprinted genes on chromosome
12qF1 in mouse induced pluripotent stem cells
Boland et al. ( 2009 )
Adult mice generated from induced pluripotent stem cells
Feng et al. ( 2010 )
Hemangioblastic derivatives from human induced
pluripotent stem cells exhibit limited expansion and
early senescence
Kiskinis and Eggan
( 2010 )[R]
Progress toward the clinical application of patient-specific
pluripotent stem cells
Laurent et al. ( 2011 )
Dynamic changes in the copy number of pluripotency and
cell proliferation genes in human ESCs and iPSCs
during reprogramming and time in culture
Bock et al. ( 2011 )
Reference maps of human ES and iPS cell variation
enable high-throughput characterization of pluripotent
cell lines
Zhao et al. ( 2011 )
Immunogenicity of induced pluripotent stem cells
Boulting et al. ( 2011 )
A functionally characterized test set of human induced
pluripotent stem cells
Young ( 2011 )[R] a
Control of the embryonic stem cell state
Ben-David and Benvenisty
( 2011 )[R] a
The tumorigenicity of human embryonic and induced
pluripotent stem cells
[R] Review articles
a Cited by Stadtfeld et al. ( 2010 )
The new emerging trend is concerned with the equivalence of iPSCs and their
human embryonic stem cell counterparts in terms of their short- and long-term
functions. The new trend has critical implications on the therapeutic potential of
iPSCs. In addition to the works by Chin et al. and Stadtfeld et al., an article
published on August 2, 2009 by Boland et al. ( 2009 ) reported an investigation of
mice derived entirely from iPSCs. Another article (Feng et al. 2010 ) appeared on
February 12, 2010 investigated abnormalities such as limited expansion and early
senescence found in human iPSCs. The Stadtfeld 2010 article (Stadtfeld et al. 2010 )
we discussed earlier appeared on May 13, 2010.
Some of the more recent citing articles of Chin et al. focused on providing
resources for more stringent evaluative and comparative studies of iPSCs. On
January 7, 2011, an article (Laurent et al. 2011 ) reported a study of genomic
stability and abnormalities in pluripotent stem cells and called for frequent genomic
monitoring to assure phenotypic stability and clinical safety. On February 4, 2011,
Bock et al. ( 2011 ) published genome-wide reference maps of DNA methylation
and gene expression for 20 previously derived human ES lines and 12 human iPS
cell lines. In a more recent article (Boulting et al. 2011 ) published on February 11,
2011, Boulting et al. established a robust resource that consists of 16 iPSC lines and
a stringent test of differentiation capacity.
iPSCs are characterized by their self-renewal and versatile ability to differentiate
into a wide variety of cell types. These properties are invaluable for regenerative
medicine. However, the same properties also make iPSCs tumorigenic or cancer
Search WWH ::

Custom Search